House Panel Subpoenaed by SEC After Report on Stock Spike

The House Ways and Means Committee and a congressional aide were subpoenaed by U.S. prosecutors and federal securities regulators, according to public disclosures.

The subpoenas are related to an investigation into whether congressional staff illegally passed on nonpublic information about a change in U.S. health-care policy that was used to trade stocks, the Wall Street Journal reported today, citing unnamed people familiar with the inquiry.

The Securities and Exchange Commission subpoenaed the House Ways and Means Committee and aide Brian Sutter, according to notices in the Congressional Record. The SEC sought documents from the committee and documents and testimony from Sutter.

Sutter is the staff director of the committee’s health subcommittee. The U.S. Attorney’s Office in Manhattan also issued a grand jury subpoena to Sutter seeking testimony, according to his disclosure.

Sutter and Sarah Swinehart, a committee spokeswoman, didn’t immediately respond to a request for comment on the subpoenas after normal business hours. John Nester, an SEC spokesman, declined to comment, as did James Margolin, a spokesman for the U.S. Attorney’s Office and Peter Carr, a Justice Department spokesman.

The probe into whether insider trading occurred on changes in health policy has been active for more than a year and was prompted by a report about how health-insurance stocks spiked ahead of government announcements favorable to those companies regarding Medicare payments, the Journal said.

The subpoenas, which are the first to Congress involving a federal insider-trading probe in almost 10 years, reflect a new focus at the SEC and the Justice Department on possible violations of securities laws based on information about government policy, the paper said.

A 2012 law requires public officials to keep confidential any non-public information about government matters that could move stock prices.

To contact the reporter on this story: David McLaughlin in Washington at dmclaughlin9@bloomberg.net

To contact the editors responsible for this story: Sara Forden at sforden@bloomberg.net Justin Blum, Michael Shepard

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.